Genus (GNS) Competitors GBX 2,459 -16.00 (-0.65%) As of 07:59 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock GNS vs. HWDN, DPH, IGG, CTY, SMWH, KYGA, CAR, PRP, AUK, and STGShould you be buying Genus stock or one of its competitors? The main competitors of Genus include Howden Joinery Group (HWDN), Dechra Pharmaceuticals (DPH), IG Group (IGG), City of London (CTY), WH Smith (SMWH), Kerry Group (KYGA), Carclo (CAR), Prime People (PRP), Aukett Swanke Group (AUK), and Strip Tinning (STG). These companies are all part of the "personal services" industry. Genus vs. Its Competitors Howden Joinery Group Dechra Pharmaceuticals IG Group City of London WH Smith Kerry Group Carclo Prime People Aukett Swanke Group Strip Tinning Howden Joinery Group (LON:HWDN) and Genus (LON:GNS) are both personal services companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability. Is HWDN or GNS a better dividend stock? Howden Joinery Group pays an annual dividend of GBX 0.21 per share and has a dividend yield of 0.0%. Genus pays an annual dividend of GBX 0.32 per share and has a dividend yield of 0.0%. Howden Joinery Group pays out 45.8% of its earnings in the form of a dividend. Genus pays out -516.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Which has better valuation and earnings, HWDN or GNS? Howden Joinery Group has higher revenue and earnings than Genus. Genus is trading at a lower price-to-earnings ratio than Howden Joinery Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHowden Joinery Group£2.35B1.92£253.42M£0.461,799.14Genus£672.80M2.40£7.87M-£0.06-39,661.29 Which has more risk & volatility, HWDN or GNS? Howden Joinery Group has a beta of 1.07, indicating that its share price is 7% more volatile than the S&P 500. Comparatively, Genus has a beta of 0.37, indicating that its share price is 63% less volatile than the S&P 500. Do analysts rate HWDN or GNS? Howden Joinery Group presently has a consensus target price of GBX 919.67, indicating a potential upside of 10.40%. Genus has a consensus target price of GBX 2,900, indicating a potential upside of 17.93%. Given Genus' stronger consensus rating and higher possible upside, analysts clearly believe Genus is more favorable than Howden Joinery Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Howden Joinery Group 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33Genus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is HWDN or GNS more profitable? Howden Joinery Group has a net margin of 10.82% compared to Genus' net margin of 1.18%. Howden Joinery Group's return on equity of 25.70% beat Genus' return on equity.Company Net Margins Return on Equity Return on Assets Howden Joinery Group10.82% 25.70% 10.70% Genus 1.18%1.41%3.31% Do insiders & institutionals have more ownership in HWDN or GNS? 67.4% of Howden Joinery Group shares are owned by institutional investors. Comparatively, 63.4% of Genus shares are owned by institutional investors. 0.9% of Howden Joinery Group shares are owned by company insiders. Comparatively, 0.6% of Genus shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media prefer HWDN or GNS? In the previous week, Genus had 3 more articles in the media than Howden Joinery Group. MarketBeat recorded 6 mentions for Genus and 3 mentions for Howden Joinery Group. Howden Joinery Group's average media sentiment score of 1.31 beat Genus' score of 0.70 indicating that Howden Joinery Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Howden Joinery Group 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Genus 1 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryHowden Joinery Group beats Genus on 12 of the 18 factors compared between the two stocks. Get Genus News Delivered to You Automatically Sign up to receive the latest news and ratings for GNS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GNS vs. The Competition Export to ExcelMetricGenusBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£1.62B£237.68M£5.78B£2.56BDividend Yield1.22%3.78%5.74%5.31%P/E Ratio-39,661.2933.2276.715,417.61Price / Sales2.404,879.29512.5797,495.16Price / Cash50.5613.1937.1727.93Price / Book2.97133.3713.669.11Net Income£7.87M-£90.99M£3.29B£5.89B7 Day Performance-5.97%0.03%1.55%0.60%1 Month Performance-7.38%18.88%6.81%3.18%1 Year Performance28.88%762.16%79.53%188.62% Genus Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GNSGenus1.8093 of 5 starsGBX 2,459-0.6%GBX 2,900+17.9%+33.8%£1.62B£672.80M-39,661.29480High Trading VolumeHWDNHowden Joinery Group2.0849 of 5 starsGBX 852-0.4%GBX 919.67+7.9%-12.7%£4.62B£2.35B1,840.1712,000DPHDechra PharmaceuticalsN/AN/AN/AN/A£4.40B£761.50M-15,464.002,457IGGIG Group3.5282 of 5 starsGBX 1,143-0.2%GBX 1,504.80+31.7%+21.0%£3.98B£949.10M1,087.542,754News CoverageAnalyst ForecastCTYCity of LondonN/AGBX 496.84+0.3%N/A+13.5%£2.46B£222.11M1,124.07N/AEarnings ReportDividend AnnouncementSMWHWH Smith2.7436 of 5 starsGBX 674.07+0.8%GBX 1,178.20+74.8%-52.6%£839.62M£1.94B14,979.3814,935Dividend IncreaseKYGAKerry GroupN/AGBX 79.70+1.4%N/A-14.0%£129.78M£6.97B18.1421,000News CoveragePositive NewsCARCarcloN/AGBX 66+1.1%N/A+75.7%£48.46M£121.22M5,500.001,059Positive NewsPRPPrime PeopleN/AN/AN/AN/A£8.15M£19.72M10.9813,100Gap DownAUKAukett Swanke GroupN/AN/AN/AN/A£5.46M£23.61M-6.3232,200Gap DownSTGStrip TinningN/AGBX 22.89-0.5%N/A-34.4%£4.17M£8.78M-118.174,060 Related Companies and Tools Related Companies Howden Joinery Group Competitors Dechra Pharmaceuticals Competitors IG Group Competitors City of London Competitors WH Smith Competitors Kerry Group Competitors Carclo Competitors Prime People Competitors Aukett Swanke Group Competitors Strip Tinning Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:GNS) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genus plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Genus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
